(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.26%) $10.87
(0.00%) $0.792
(-0.18%) $92.41
Live Chart Being Loaded With Signals
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer...
Stats | |
---|---|
Today's Volume | 1.78M |
Average Volume | 1.24M |
Market Cap | 127.96M |
EPS | $-53.13 ( 2023-09-29 ) |
Last Dividend | $0.360 ( 2023-03-06 ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.29 |
ATR14 | $0.0360 (5.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-06 | Kelly Steven | Buy | 600 000 | Stock Option (Right to Buy) |
2023-06-06 | Zweifach Sanford S | Buy | 38 700 | Stock Option (Right to Buy) |
2023-06-06 | Morris Richard Steven | Buy | 238 000 | Stock Option (Right to Buy) |
2023-06-06 | Torok Michael | Buy | 38 700 | Stock Option (Right to Buy) |
2023-06-06 | Klichinsky Michael | Buy | 238 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
76.65 |
Last 87 transactions |
Buy: 18 644 112 | Sell: 1 508 721 |
Volume Correlation
Sesen Bio Inc Correlation
10 Most Positive Correlations | |
---|---|
BOCH | 0.945 |
SHSP | 0.905 |
DYNT | 0.846 |
SGC | 0.836 |
MMAC | 0.83 |
WWD | 0.829 |
SYKE | 0.826 |
LIVE | 0.825 |
DGLY | 0.823 |
ECOR | 0.817 |
10 Most Negative Correlations | |
---|---|
GAINL | -0.898 |
APOP | -0.887 |
TDAC | -0.884 |
RMRM | -0.88 |
ISNS | -0.872 |
SVOK | -0.829 |
VERA | -0.822 |
AHPI | -0.801 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sesen Bio Inc Correlation - Currency/Commodity
Sesen Bio Inc Financials
Annual | 2022 |
Revenue: | $40.00M |
Gross Profit: | $40.00M (100.00 %) |
EPS: | $-1.990 |
Q3 | 2023 |
Revenue: | $3.83M |
Gross Profit: | $3.83M (100.00 %) |
EPS: | $-0.530 |
Q2 | 2023 |
Revenue: | $3.56M |
Gross Profit: | $3.56M (100.00 %) |
EPS: | $-0.490 |
Q1 | 2023 |
Revenue: | $3.24M |
Gross Profit: | $3.24M (100.00 %) |
EPS: | $-1.930 |
Financial Reports:
No articles found.
Sesen Bio Inc Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.360 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.360 | 2023-03-06 |
Last Dividend | $0.360 | 2023-03-06 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.360 | -- |
Avg. Dividend % Per Year | 18.77% | -- |
Score | 4.82 | -- |
Div. Sustainability Score | 5.13 | |
Div.Growth Potential Score | 0.276 | |
Div. Directional Score | 2.70 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.360 | 56.30% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -1.605 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.761 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.910 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.53 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.27 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 6.42 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0257 | -1.500 | 9.57 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.34 | 1.000 | 6.91 | 6.91 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0199 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0166 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0593 | -1.500 | 9.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -1.510 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.292 | 1.000 | 9.49 | 9.49 | [0.2 - 2] |
assetTurnoverTTM | 0.474 | 0.800 | -0.172 | -0.138 | [0.5 - 2] |
Total Score | 5.13 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.312 | 1.000 | -0.133 | 0 | [1 - 100] |
returnOnEquityTTM | -0.910 | 2.50 | -7.21 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0166 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0199 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0158 | 1.000 | -2.10 | 0 | [0.1 - 0.5] |
Total Score | 0.276 |
Sesen Bio Inc
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators